ALR Technologies SG (ALRTF) Gains from Investment Securities (2021 - 2023)
ALR Technologies SG posted quarterly Gains from Investment Securities of $412.0 million for Q4 2023, down 92.51% on a QoQ basis from $5.5 billion in Q4 2021.
ALR Technologies SG (ALRTF) has 2 years of Gains from Investment Securities data on file, last reported at $412.0 million in Q4 2023.
- For the quarter ending Q4 2023, Gains from Investment Securities changed N/A year-over-year to $412.0 million; the trailing twelve-month figure through Dec 2023 stood at $412.0 million (changed N/A YoY), and the FY2023 full-year result was $412.0 million, up 168251.02% from the prior year.
- Gains from Investment Securities for Q4 2023 stood at $412.0 million, down from $5.5 billion in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $5.5 billion in Q4 2021 and bottomed at $412.0 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ALR Technologies SG | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 411.97 Mn |
| Dec 31, 2023 | 411.97 Mn |
| Dec 31, 2021 | 5.50 Bn |
| Dec 31, 2021 | 5.50 Bn |